- Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
-
Nishikawa , Hasegawa K, Yabuno A, Yoshida H, Yasuda M, Kozawa E, Fujiwara K
- KMID: 2413861
- J Gynecol Oncol.
- 2017 Jan;28(1):e25.
- doi: 10.3802/jgo.2017.28.e25
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
